Note 5 - Certain Balance Sheet Accounts - Schedule of Receivables (Details) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Trade receivables, net | $ 11,711 | $ 0 |
| OMIDRIA royalty receivables | 6,109 | 6,443 |
| Novo Nordisk receivable | 3,370 | 3,724 |
| Other receivables | 111 | 750 |
| Total receivables | $ 21,301 | $ 10,917 |
| X | ||||||||||
- Definition Represents the amount of milestone payment receivable. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of royalty receivable classified as current. No definition available.
|
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|